human
coronavirus
two
known
serogroup
name
caus
one
third
common
cold
may
associ
seriou
diseas
nosocomi
respiratori
infect
enterocol
pericard
neurolog
disord
reliabl
method
detect
clinic
sampl
need
better
understand
role
patholog
first
step
design
diagnost
procedur
sensit
specif
two
viral
diagnost
assay
compar
experiment
cell
cultur
model
indirect
immunofluoresc
assay
use
monoclon
antibodi
revers
transcriptasepolymeras
chain
reaction
amplif
viral
rna
infect
cell
immunofluoresc
detect
human
coronavirus
cell
infect
moi
low
log
tcid
ml
log
pfuml
versu
revers
transcriptasepolymeras
chain
reaction
amplif
log
tcid
ml
log
pfuml
fals
posit
signal
human
respiratori
pathogen
influenza
viru
respiratori
syncyti
viru
adenoviru
moreov
assay
coronaviru
serogroupspecif
result
demonstr
potenti
use
immunofluoresc
monoclon
antibodi
revers
transcriptasepolymeras
chain
reaction
rna
amplif
rapid
detect
human
coronavirus
infect
cell
cultur
method
could
appli
clinic
specimen
diagnosi
human
infect
human
coronavirus
hcv
group
envelop
positivestrand
rna
virus
repres
two
known
serogroup
design
first
isol
hamr
procknow
mcintosh
et
al
ubiquit
well
studi
virus
associ
common
cold
human
myint
experiment
prototyp
strain
infect
human
astrocyt
microglia
primari
cultur
bonavia
et
al
rna
detect
signific
proport
human
autopsi
brain
sampl
arbour
talbot
unpublish
result
consist
neurotrop
potenti
clinic
studi
variou
report
associ
human
coronavirus
nosocomi
respiratori
infect
prematur
newborn
diagnos
indirect
immunofluoresc
sizun
et
al
enterocol
neonat
evid
human
coronavirus
shown
electron
microscopi
chani
et
al
serodiagnos
human
coronavirus
also
associ
exacerb
asthma
nicholson
et
al
pericard
riski
hovi
therefor
virus
might
involv
diseas
far
seriou
mild
upper
respiratori
tract
infect
epidemiolog
studi
evalu
patholog
potenti
human
coronavirus
requir
reliabl
rapid
method
detect
clinic
sampl
nasal
tracheal
aspir
cerebrospin
fluid
tissu
variou
method
describ
detect
human
coronavirus
viru
isol
cell
cultur
difficult
timeconsum
effect
adapt
strain
specialis
laboratori
serolog
method
mainli
base
elisa
use
epidemiolog
studi
allow
rapid
viru
identif
kraaijeveld
et
al
mcnaughton
et
al
gill
et
al
immunofluoresc
rabbit
antisera
develop
rapid
detect
human
coronavirus
nasopharyng
secret
mcintosh
et
al
howev
specif
techniqu
disput
crossreact
two
human
coronavirus
strain
myint
sensit
difficult
ascertain
sinc
human
coronavirus
antigen
detect
prospect
evalu
children
hospit
respiratori
tract
infect
detect
nucleic
acid
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
nasal
aspir
myint
et
al
nest
pcr
appar
sensit
combin
viral
isol
cell
cultur
serolog
aim
current
studi
compar
sensit
specif
two
assay
immunofluoresc
monoclon
antibodi
mab
rtpcr
rapid
detect
human
coronavirus
experiment
cell
cultur
model
first
step
design
rapid
diagnost
procedur
clinic
sampl
suscept
cell
line
human
embryon
lung
human
rectal
tumor
strain
human
coronavirus
origin
obtain
american
type
cultur
collect
atcc
rockvil
md
cell
grown
humidifi
atmospher
contain
vv
co
earl
minim
essenti
medium
emem
hank
vv
supplement
wv
sodium
bicarbon
vgml
gentamicin
canadian
life
technolog
burlington
ont
fetal
bovin
serum
fb
vv
vv
cell
virus
plaquepurifi
twice
grown
either
cell
cell
describ
previous
jouvenn
et
al
mounir
talbot
third
passag
suscept
cell
line
titer
tcid
ml
pfuml
fourth
passag
suscept
cell
line
titer
tcid
ml
pfuml
laboratori
stock
kept
use
experi
human
respiratori
syncyti
viru
rsv
long
strain
subgroup
human
adenoviru
human
influenza
viru
aussr
strain
virus
obtain
dr
michel
trudel
serg
dea
jit
arora
armandfrappi
institut
respect
approxim
cell
ml
emem
hank
vv
wv
sodium
bicarbon
vv
fb
mix
cm
tissu
cultur
flask
corn
cambridg
ml
viru
stock
dilut
give
multipl
infect
moi
equal
success
logarithm
dilut
incub
took
place
humidifi
chamber
incub
vv
co
last
h
h
previous
determin
optim
time
end
incub
period
cellfre
supernat
remov
cell
monolay
wash
twice
phosphat
buffer
salin
pb
dissoci
wv
trypsin
canadian
life
technolog
cell
wv
trypsin
plu
mm
edta
canadian
life
technolog
cell
wash
pb
min
rpm
beckman
centrifug
cell
resuspend
ml
pb
total
vl
infect
cell
suspens
deposit
onto
well
glass
slide
flow
icn
biomed
mississauga
ont
dri
laminar
flow
hood
fix
aceton
min
slide
supernat
residu
cell
suspens
use
immedi
store
neg
control
consist
noninfect
cell
virusspecif
mab
produc
laboratori
standard
hybridoma
technolog
use
indirect
immunofluoresc
test
cell
infect
variou
moi
either
use
mous
mab
detect
mous
mab
detect
two
mab
shown
western
immunoblot
radioimmunoprecipit
recognis
surfac
glycoprotein
respect
data
shown
primari
antibodi
dilut
ad
thaw
slide
incub
h
follow
three
wash
pb
addit
fluoresceinconjug
mousespecif
goat
secondari
antibodi
cappel
durham
nc
incub
min
three
wash
pb
slide
stain
evan
blue
wv
distil
water
mount
glycerol
pb
slide
observ
immedi
leica
fluoresc
microscop
store
later
observ
monolay
score
neg
contain
cell
typic
fluoresc
ten
field
contain
least
cell
isotyp
control
antibodi
consist
mab
unrel
plant
viru
robbin
et
al
infecti
viru
titer
sampl
use
evalu
diagnost
techniqu
measur
use
immunoperoxidas
method
suscept
cell
confluenc
inocul
logarithm
dilut
sampl
linbro
plate
flow
mclean
va
day
incub
humidifi
chamber
vv
co
cell
wash
pb
fix
vv
hydrogen
peroxid
sigma
methanol
min
wash
pb
incub
h
vv
co
appropri
antivir
antibodi
control
reaction
use
mab
cell
mab
cell
cell
wash
five
time
pb
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
kpl
gaithersburg
maryland
ad
incub
h
without
co
bound
antibodi
detect
incub
wv
diaminobenzidinetetrahydrochlorid
biorad
richmond
ca
vv
hydrogen
peroxid
sigma
pb
chromogen
reaction
amplifi
region
correspond
nucleotid
nucleocapsid
protein
gene
schreiber
et
al
bonavia
et
al
b
amplifi
region
correspond
nucleotid
nucleocapsid
protein
gene
stewart
et
al
mix
vl
pb
spun
g
min
eppendorf
centrifug
model
resuspend
vl
vv
diethyl
pyrocarbon
depc
sigma
solut
boil
min
cellular
debri
elimin
centrifug
min
g
supernat
use
immedi
store
bonavia
et
al
oligonucleotid
primer
pair
use
rtpcr
describ
tabl
rtpcr
protocol
use
describ
previous
use
abl
detect
human
coronavirus
antigen
viral
prepar
show
viral
titer
either
log
tcid
ml
monitor
immunoperoxidas
assay
detect
infecti
virion
cell
infect
sampl
test
tabl
correspond
log
pfuml
respect
hand
rtpcr
sensit
virus
sinc
allow
detect
human
coronavirus
prepar
contain
low
log
tcid
ml
hcvwa
stop
deioniz
water
infecti
viru
titer
calcul
karber
method
payment
trudel
neg
posit
control
consist
noninfect
cell
cell
infect
appropri
viru
stock
respect
obtain
total
cellular
rna
infect
control
cell
vl
cell
suspens
suscept
cell
infect
indic
moi
yield
viru
prepar
indic
infecti
viral
titer
measur
immunoperoxidas
assay
viral
prepar
use
use
mab
rtpcr
primer
pair
respect
fig
correspond
log
pfuml
respect
importantli
rtpcr
assay
detect
input
virion
sinc
rtpcr
perform
rna
extract
cell
inocul
viru
viral
penetr
cell
neg
data
shown
howev
possibl
evalu
sensit
rtpcr
assay
term
amount
viral
rna
sinc
proport
total
cellular
rna
known
mab
show
characterist
cytoplasm
fluoresc
human
coronavirusesinfect
cell
fig
noninfect
cell
data
shown
control
respiratori
human
virus
influenza
viru
adenoviru
respiratori
syncyti
viru
yield
neg
result
data
shown
mab
specif
one
human
coronavirus
serogroup
sinc
fluoresc
observ
mab
use
cell
mab
use
cell
fig
good
correl
result
obtain
rtpcr
two
method
detect
human
coronavirus
strain
compar
indirect
immunofluoresc
virusspecif
mab
rtpcr
cell
cultur
experiment
model
use
rather
clinic
sampl
sinc
assay
undertaken
human
sampl
allow
precis
analysi
sensit
specif
human
coronavirus
detect
method
number
infecti
viru
particl
coronaviruscontain
secret
unknown
moreov
refer
method
cultur
clinic
sampl
difficult
carri
final
possibl
doubl
viral
infect
may
advers
affect
studi
specif
valenti
et
al
wilson
et
al
indirect
immunofluoresc
use
routin
diagnosi
viral
respiratori
infect
use
routin
evalu
human
coronavirus
infect
result
studi
confirm
appropri
sensit
techniqu
inde
allow
detect
human
coronavirus
cell
suspens
infecti
viral
titer
log
tcid
ml
log
tcid
ml
fals
posit
signal
observ
human
influenza
viru
human
respiratori
syncyti
viru
human
adenoviru
importantli
mab
human
coronavirus
serogroupspecif
polyclon
antibodi
use
previou
studi
show
serogroup
specif
sinc
cell
yield
posit
signal
antibodi
use
mcintosh
et
al
epidemiolog
studi
shown
patient
infect
strain
human
coronavirus
rare
circul
antibodi
strain
kapikian
et
al
therefor
would
interest
distinguish
clinic
studi
serogroupspecif
test
describ
would
use
purpos
rtpcr
techniqu
specif
sensit
sinc
allow
detect
human
coronavirus
cell
suspens
viral
titer
low
log
tcid
ml
log
tcid
ml
publish
report
detect
human
coronavirus
rtpcr
sensit
nest
pcr
techniqu
compar
clinic
sampl
two
techniqu
elisa
cell
cultur
latter
avail
myint
et
al
pcr
techniqu
appear
sensit
either
cell
cultur
elisa
less
two
associ
techniqu
specif
clinic
use
difficult
ascertain
possibl
dual
infect
human
coronavirus
either
rhinoviru
influenza
viru
investig
use
classic
singlestep
rna
extract
chomczynski
sacchi
requir
h
execut
undertook
two
pcr
amplif
round
would
difficult
obtain
result
within
day
use
protocol
simpl
cell
lysi
depctreat
water
elimin
protein
cell
wall
allow
us
perform
rtpcr
sever
sampl
rapidli
techniqu
use
would
appropri
treat
larg
number
human
sampl
contain
cell
alreadi
report
use
rtpcr
techniqu
clinic
sampl
bonavia
et
al
interestingli
immunoperoxydas
assay
use
valid
quantif
viru
detect
rtpcr
appear
sensit
two
techniqu
like
amplif
afford
anoth
round
viru
replic
suscept
cell
howev
assay
suitabl
clinic
applic
sinc
result
obtain
sever
day
requir
viral
infect
work
well
cell
cultureadapt
prototyp
strain
may
possibl
field
viru
isol
result
current
studi
demonstr
potenti
use
mabbas
rtpcr
detect
human
coronavirus
interestingli
recent
emphas
nucleic
acid
amplif
techniqu
diagnosi
respiratori
tract
infect
clinic
laboratori
warrant
rapid
convent
method
avail
case
coronavirus
rhinovirus
enterovirus
ieven
goossen
result
current
studi
show
feasibl
techniqu
rapid
detect
human
coronavirus
rtpcr
techniqu
present
current
studi
show
good
sensit
specif
two
known
human
coronavirus
serogroup
